Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,690 | 19,750 | 28,921 | 34,475 | 32,736 |
| Marketable Securities | 42,460 | 66,020 | 63,601 | 62,553 | 13,418 |
| Receivables | 624 | 0 | 6,582 | 4,335 | 2,689 |
| Inventories | 4,550 | 0 | 0 | 0 | 0 |
| Other current assets | 1,716 | 7,130 | 536 | -16,354 | 359 |
| TOTAL | $73,040 | $92,900 | $99,640 | $85,009 | $49,202 |
| Non-Current Assets | |||||
| PPE Net | 36,290 | 33,010 | 32,712 | 34,297 | 27,871 |
| Investments And Advances | 27,430 | 30,840 | 35,883 | 18,170 | 14,742 |
| Other Non-Current Assets | 210 | 150 | 145 | 100 | 1,996 |
| TOTAL | $63,930 | $64,000 | $68,740 | $52,567 | $44,609 |
| Total Assets | $136,990 | $156,910 | $168,380 | $137,581 | $93,811 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,550 | 5,550 | 4,663 | 2,170 | 6,290 |
| Accrued Expenses | N/A | 0 | 0 | 2,170 | 0 |
| Other current liabilities | 5,320 | 2,730 | 4,181 | 4,100 | 3,167 |
| TOTAL | $13,310 | $9,400 | $10,687 | $12,048 | $12,948 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,520 | 1,600 | 1,674 | 1,740 | 1,826 |
| Other Non-Current Liabilities | 280 | 280 | 242 | 180 | 103 |
| TOTAL | $14,130 | $16,260 | $18,794 | $18,590 | $13,007 |
| Total Liabilities | $27,460 | $25,680 | $29,481 | $30,650 | $25,955 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 30 | 20 | 21 |
| Retained earnings | -200,300 | -177,230 | -168,607 | -157,020 | -124,605 |
| Other shareholders' equity | -490 | -140 | -632 | -809 | -1,154 |
| TOTAL | $109,530 | $131,220 | $138,899 | $106,931 | $67,856 |
| Total Liabilities And Equity | $136,990 | $156,900 | $168,380 | $137,581 | $93,811 |